Suppr超能文献

经皮注射纤维蛋白胶治疗纵隔淋巴管瘤:4年临床成功的病例报告

Percutaneous therapy of a mediastinal lymphangioma with fibrin glue: case report with clinical success after 4 years.

作者信息

Zhou Siyu, Dong Siyuan, Du Jiang

机构信息

Department of Thoracic Surgery, First Hospital of China Medical University, NO.155 of north Nanjing street, Shenyang, Liaoning, China.

出版信息

BMC Surg. 2018 Jan 24;18(1):4. doi: 10.1186/s12893-018-0339-x.

Abstract

BACKGROUND

Lymphangioma of the mediastinum is a rare benign tumor, and most of the cases are treated by a surgical approach.

CASE PRESENTATION

This work reports the case of a 62-year-old female with a large lymphangioma extending from her neck to her abdomen with dysphagia, dyspnea, and cough for 2 months. Because of the location of the mass, only bilateral excision could remove the multiloculated cyst completely. However, the patient's overall physical condition was very poor, and we thought she could not tolerate the bilateral surgery. Therefore, the patient was treated by percutaneous aspiration drainage followed by fibrin glue injection. Our method has never been reported in the treatment of such a large intrathoracic lesion thus far.

CONCLUSIONS

Percutaneous puncture and aspiration drainage followed by fibrin glue injection may be a feasible treatment option for the therapy of intrathoracic lymphangioma, with less damage than with other therapies.

摘要

背景

纵隔淋巴管瘤是一种罕见的良性肿瘤,大多数病例通过手术方法治疗。

病例介绍

本文报道了一名62岁女性患者的病例,其患有一个从颈部延伸至腹部的巨大淋巴管瘤,伴有吞咽困难、呼吸困难和咳嗽2个月。由于肿块的位置,只有双侧切除才能完全切除多房性囊肿。然而,患者的整体身体状况非常差,我们认为她无法耐受双侧手术。因此,对该患者采用经皮穿刺抽吸引流并注入纤维蛋白胶进行治疗。迄今为止,我们的方法在治疗如此大的胸腔内病变方面尚未见报道。

结论

经皮穿刺抽吸引流并注入纤维蛋白胶可能是治疗胸腔内淋巴管瘤的一种可行的治疗选择,与其他治疗方法相比损伤较小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/5782390/29e2acd3826a/12893_2018_339_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验